Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The dawn of mRNA vaccines: The COVID-19 case
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 511-520
Open Access | Times Cited: 385

Showing 1-25 of 385 citing articles:

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, et al.
International Journal of Pharmaceutics (2021) Vol. 601, pp. 120586-120586
Open Access | Times Cited: 1001
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 339
Evolution of drug delivery systems: From 1950 to 2020 and beyond
Haesun Park, Andrew Otte, Kinam Park
Journal of Controlled Release (2021) Vol. 342, pp. 53-65
Open Access | Times Cited: 266
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 251
Nanoparticles in the clinic: An update post COVID‐19 vaccines
Aaron C. Anselmo, Samir Mitragotri
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 228
Non-viral vectors for RNA delivery
Yi Yan, Xiaoyu Liu, Lu An, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 241-279
Open Access | Times Cited: 212
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Yi Ju, Wen Shi Lee, Emily H. Pilkington, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 11769-11780
Open Access | Times Cited: 195
COVID-19 mRNA vaccines: Platforms and current developments
Gábor Szabó, Azita J. Mahiny, Irena Vlatkovic
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1850-1868
Open Access | Times Cited: 194
Principles for designing an optimal mRNA lipid nanoparticle vaccine
Edo Kon, Uri Elia, Dan Peer
Current Opinion in Biotechnology (2021) Vol. 73, pp. 329-336
Open Access | Times Cited: 181
Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
Sun Chang Kim, Simranjeet Singh Sekhon, Woo‐Ri Shin, et al.
Molecular & Cellular Toxicology (2021) Vol. 18, Iss. 1, pp. 1-8
Open Access | Times Cited: 154
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size
Jiaxing Di, Zhili Du, Kangzeng Wu, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 1, pp. 105-114
Open Access | Times Cited: 121
Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic
Samagra Jain, Abhijeet K. Venkataraman, Marissa E. Wechsler, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114000-114000
Open Access | Times Cited: 110
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 108
Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series
Asra Fazlollahi, Mahdi Zahmatyar, Maryam Noori, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 104
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 103
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
Erik Oude Blenke, Eivor Örnskov, Christian Schöneich, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 2, pp. 386-403
Open Access | Times Cited: 101
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
Bioconjugate Chemistry (2023) Vol. 34, Iss. 6, pp. 941-960
Open Access | Times Cited: 87
Vaccine-like nanomedicine for cancer immunotherapy
Yunfei Yi, Mian Yu, Wen Li, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 760-778
Closed Access | Times Cited: 80
Regulating trained immunity with nanomedicine
Mandy M. T. van Leent, Bram Priem, David P. Schrijver, et al.
Nature Reviews Materials (2022) Vol. 7, Iss. 6, pp. 465-481
Open Access | Times Cited: 79
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 78
Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 73
Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 70
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
Kepan Chen, Na Fan, Hai Huang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 39
Open Access | Times Cited: 67
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
Sofie Meulewaeter, Gust Nuytten, Miffy H. Y. Cheng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 149-160
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top